GlassScriptPhysician profile
Emily Maru
NPI 1578189650
$4,531.64
in general payments reported to CMS, 2019-2025
35 companies · $2,394 in 2025
The $2,394 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $709 · 2024: $1,429 · 2025: $2,394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,180 · Education: $240 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,179.88 |
| Education | $239.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $901.31 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $565.83 | 2024-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $563.97 | 2023-2025 | |
| Pfizer INC. | $374.25 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $247.31 | 2023-2025 | Pylarify |
| Immunitybio, INC. | $190.92 | 2025 | |
| Tolmar, INC. | $184.44 | 2023-2025 | Eligard, Jatenzo |
| Merck Sharp & Dohme LLC | $162.76 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astellas Pharma US INC | $157.08 | 2023-2025 | Myrbetriq, Xtandi |
| Urogen Pharma, INC. | $133.42 | 2023-2025 | Jelmyto |
| Novartis Pharmaceuticals Corporation | $125.80 | 2024-2025 | |
| Abbvie INC. | $119.99 | 2024-2025 | |
| Endo USA, INC. | $72.37 | 2024-2025 | Aveed, Xiaflex |
| Tempus Ai, INC | $69.28 | 2024 | Xt Cdx |
| Janssen Scientific Affairs, LLC | $65.92 | 2025 | Erleada |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $55.51 | 2024-2025 | Adstiladrin |
| Seagen INC. | $54.99 | 2025 | |
| Myriad Genetic Laboratories, INC. | $52.82 | 2023 | |
| Telix Pharmaceuticals | $45.70 | 2024 | Illuccix |
| Abc Home Medical Supply, INC. | $39.96 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $38.06 | 2025 | |
| Coloplast Corp | $33.28 | 2025 | |
| Axonics, INC. | $29.07 | 2023 | Axonics |
| Boston Scientific Corporation | $28.47 | 2023 | Solyx Sis System |
| Endo Pharmaceuticals INC. | $24.24 | 2023 | Xiaflex, Aveed, Edex |
| Olympus America INC. | $24.11 | 2024 | Itind System |
| Antares Pharma, INC. | $23.97 | 2025 | Xyosted |
| Bioprotect Medical, INC. | $22.01 | 2025 | Bioprotect Balloon Implant System |
| Accord Healthcare, INC. | $20.49 | 2025 | |
| Civco Medical Instruments | $20.05 | 2024 | |
| Caris Mpi, INC. | $19.86 | 2025 | Mi Cancer Seek |
| Avyxa Pharma, LLC | $18.92 | 2025 | |
| Alnylam Pharmaceuticals INC. | $17.37 | 2025 | Givlaari |
| Sun Pharmaceutical Industries INC. | $14.25 | 2024 | |
| Teleflex LLC | $13.86 | 2024 | Solesta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Maru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.